AI: DeepSeek (deepseek-chat)

Q: {
  "guidelineId": "uae-bsuh-guidelines-september-2016-pdf",
  "fieldsProcessed": [
    "humanFriendlyName",
    "organisation",
    "yearProduced",
    "summary"
  ],
  "enhancedFields": 4,
  "contentLength": 890
}

A: {
  "success": true,
  "enhancedFields": [
    {
      "field": "humanFriendlyName",
      "oldValue": null,
      "newValue": "Uterine Artery Embolisation (UAE) Guidelines for Fibroids",
      "action": "added"
    },
    {
      "field": "organisation",
      "oldValue": null,
      "newValue": "RCOG",
      "action": "added"
    },
    {
      "field": "yearProduced",
      "oldValue": null,
      "newValue": "I cannot find a publication year in the provided text. The guideline text does not include a specific 4-digit year",
      "action": "added"
    },
    {
      "field": "summary",
      "oldValue": null,
      "newValue": "**Summary of UAE Guidelines for Symptomatic Fibroids:** - **Indications:** UAE is effective for lifestyle-altering symptoms (heavy menstrual bleeding, severe dysmenorrhoea, anaemia) or fibroids causing pain/mass effect on bladder/bowel. - **Contraindications:** Viable pregnancy, gynaecological malignancy, active uterine infection. - **Pre-procedure:** Gynaecological review required to confirm diagnosis and discuss alternatives. - **Procedure:** Embolisation of uterine arteries, often using arterial closure devices. High technical success rate. - **Post-procedure:** Monitor for complications; manage pain. Follow-up MRI recommended. Address concerns promptly",
      "action": "added"
    }
  ]
}